Precision BioSciences (DTIL) Tops Q1 EPS by 9c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of ($0.46), $0.09 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $3.32 million versus the consensus estimate of $6.63 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M